SUBSCRIBE
SUBSCRIBE
News   Drug Development

GlaxoSmithKline’s Herpes Vaccine Fails in Trial, US National Institutes of Health (NIH) Says

September 30, 2010 | 
1 min read
WASHINGTON, Sept 30 (Reuters) - GlaxoSmithKline (GSK.L) (GSK.N) said on Thursday that it was stopping development of a genital herpes vaccine after it failed to protect women against the virus.
Clinical research Phase III
GlaxoSmithKline
MORE ON THIS TOPIC
Courtesy of Sarepta Therapeutics
Duchenne muscular dystrophy
Sarepta Seeks to Strengthen Elevidys’ Case With Data in Older Kids
May 16, 2025
 · 
2 min read
 · 
Tristan Manalac
Crumpled paper balls fly into a miniature bucket, the concept of searching for new ideas
Lung cancer
GSK, iTeos Abandon TIGIT Therapy, Adding to Long List of Recent Class Failures
May 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Stand out from the crowd and different creative idea concepts , Longest light ladder glowing and aiming high to goal target among other short ladders on green background with shadows . 3D rendering.
Obesity
Lilly’s Zepbound Secures “Superior Benefit-Risk Ratio” Over Novo’s Wegovy
May 12, 2025
 · 
2 min read
 · 
Tristan Manalac
istock/ArtemisDiana
PARTNERED
Where AI Adds Real Value in Clinical Development
May 12, 2025
 · 
7 min read
 · 
BioSpace Insights